Join over 250 leaders, experts and researchers at the Formulation & Drug Delivery US Series, connecting global pharma, biotech and academia for high-level discussions on the latest innovations for biopharmaceutical development.

The Formulation & Drug Delivery Congress will discuss the state of the industry, looking at new strategies for optimizing biologic formulations such as antibodies, proteins and vaccines, as well as highlighting key updates in amorphous solid dispersions and combination products.

Alongside this, The Inhalation & Respiratory Drug Delivery Congress will examine the latest developments in inhaled vaccines and antibiotics, alongside challenges and trends in generic formulation.

Featuring over 55+ renowned industry speakers from leading organisations such as Merck, Takeda and AstraZeneca, this programme will allow you to discuss the key topics that interest you.

View the Programme: https://bit.ly/33nCbI2

 2020 Live Webinars:

‘The Design And Development Of A Connected Inhalation System To Help With Monitoring And Patient Adherence’ – Hosted by Paul Upham, Head, Smart Devices, Genentech 

“Understanding Supersaturation Of Small Molecule To Improve Oral Bioavailability”  – Hosted by Sudhakar Garad, Global Head of Chemical and Pharmaceutical Profiling, Novartis Institutes for BioMedical Research

“Ocular biopharmaceutics: impact of modeling and simulation on topical ophthalmic formulation development” – Hosted by Hovik Gukasyan, Associate Director, Early Development Formulation and Physical Chemistry, Allergan

Webinar Registration:  https://bit.ly/2qvy91O

Go Social: For the latest conference updates follow us on Twitter @FDDCongress and join the congress conversation on #FDDUS20 

For more information about the event, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk